JPI-EC-AMR - ERA-NET Cofund for establishing synergies between the Joint Programming Initiative on Antimicrobial Resistance Research and Horizon 2020 (11/2015 - 10/2020).
Such synergies have been created among 19 countries in Europe and beyond through the EU Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). JPIAMR has developed a Strategic Research Agenda (SRA) which defines the strategic and scientific priorities benefiting from co-ordination and co-operation at the European level.
In the ERA-NET Cofund JPI-EC-AMR € 23 million of national funds will be combined with a highly incentivising EC top-up fund to support a new transnational research programme. The aim of this programme is to unravel the complex dynamics of selection and transmission of antimicrobial resistance (AMR) according to the One Health concept.
JPI-EC-AMR will launch additional joint transnational calls (JTC) without EC co-funding under the framework of the SRA. and perform additional joint actions in close collaboration with JPIAMR actions. JPI-EC-AMR will provide a better, quantitative understanding of drug-resistant bacteria in animals, foods, and the environment and to what extent they contribute to the burden of antibiotic-resistant infections in humans.